Projects funded by the NCN
Hepatitis B virus heterogeneity as a prognostic factor of sustained interferon therapy in chronic hepatitis B.
2013/11/N/NZ7/00377
Keywords:
HBV Peg IFN-α MALDI-TOF MS quasispecies prognostic factor
Descriptors:
- NZ7_1: Epidemiology
- NZ7_12: Prevention of human diseases
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego
woj. pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 6 - announced on 2013-09-16
Amount awarded: 99 970 PLN
Project start date (Y-m-d): 2014-08-01
Project end date (Y-m-d): 2017-01-31
Project duration:: 30 months (the same as in the proposal)
Project status: Project settled